CUVITRU (Baxalta US Inc.)


Welcome to the PulseAid listing for the CUVITRU drug offered from Baxalta US Inc.. This Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.

LABELER NAME / MANUFACTURER: Baxalta US Inc.
NON-PROPRIETARY NAME: Human Immunoglobulin G
SUBSTANCE NAME: HUMAN IMMUNOGLOBULIN G
TYPE: PLASMA DERIVATIVE
PHARMA CLASS: Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient]
ROUTE: INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2016-10-18
END MARKETING DATE: 0000-00-00


CUVITRU PLASMA DERIVATIVE Details:

Item DescriptionCUVITRU from Baxalta US Inc.
LABELER NAME: Baxalta US Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/5mL)
START MARKETING DATE: 2016-10-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0944-2850_a75cce13-0654-4513-bdd0-a3f50a36d47b
PRODUCT NDC: 0944-2850
APPLICATION NUMBER: BLA125596

Other HUMAN IMMUNOGLOBULIN G Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aptevo BioTherapeutics LLCWINRHO
Baxalta US Inc.GAMMAGARD Liquid
Bio Products Laboratory LimitedGammaplex
Biotest Pharmaceuticals CorporationBIVIGAM
Cangene BioPharma, LLCWINRHO
CSL Behring AGCarimune
GRIFOLS USA, LLCFlebogamma
KEDRION BIOPHARMA, INC.GAMMAKED
Octapharma ABOctagam Immune Globulin (Human)
Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.Octagam Immune Globulin (Human)
Octapharma USA IncOctagam Immune Globulin (Human)